Patent · US Active

Methods and compositions for treating hemophilia B

US9629930B2 · kind B2 · utility

8Cited by
36References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 8, 2015
Grant dateApr 25, 2017
Priority date
Expiry dateOct 18, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2005/0661
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for insertion of Factor IX (FIX) sequences into the genome of a cell for treating hemophilia B.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.